36316110|t|PLK2 Single Nucleotide Variant in Gastric Cancer Patients Affects miR-23b-5p Binding.
36316110|a|PURPOSE: Chromosomal instability is a hallmark of gastric cancer (GC). It can be driven by single nucleotide variants (SNVs) in cell cycle genes. We investigated the associations between SNVs in candidate genes, PLK2, PLK3, and ATM, and GC risk and clinicopathological features. MATERIALS AND METHODS: The genotyping study included 542 patients with GC and healthy controls. Generalized linear models were used for the risk and clinicopathological association analyses. Survival analysis was performed using the Kaplan-Meier method. The binding of candidate miRs was analyzed using a luciferase reporter assay. RESULTS: The PLK2 Crs15009-Crs963615 haplotype was under-represented in the GC group compared to that in the control group (Pcorr=0.050). Male patients with the PLK2 rs963615 CT genotype had a lower risk of GC, whereas female patients had a higher risk (P=0.023; P=0.026). The PLK2 rs963615 CT genotype was associated with the absence of vascular invasion (P=0.012). The PLK3 rs12404160 AA genotype was associated with a higher risk of GC in the male population (P=0.015). The ATM Trs228589-Ars189037-Grs4585 haplotype was associated with a higher risk of GC (P<0.001). The ATM rs228589, rs189037, and rs4585 genotypes TA+AA, AG+GG, and TG+GG were associated with the absence of perineural invasion (P=0.034). In vitro analysis showed that the cancer-associated miR-23b-5p mimic specifically bound to the PLK2 rs15009 G allele (P=0.0097). Moreover, low miR-23b expression predicted longer 10-year survival (P=0.0066) in patients with GC. CONCLUSIONS: PLK2, PLK3, and ATM SNVs could potentially be helpful for the prediction of GC risk and clinicopathological features. PLK2 rs15009 affects the binding of miR-23b-5p. MiR-23b-5p expression status could serve as a prognostic marker for survival in patients with GC.
36316110	0	4	PLK2	Gene	10769
36316110	34	48	Gastric Cancer	Disease	MESH:D013274
36316110	49	57	Patients	Species	9606
36316110	136	150	gastric cancer	Disease	MESH:D013274
36316110	152	154	GC	Disease	MESH:D013274
36316110	298	302	PLK2	Gene	10769
36316110	304	308	PLK3	Gene	1263
36316110	314	317	ATM	Gene	472
36316110	323	325	GC	Disease	MESH:D013274
36316110	422	430	patients	Species	9606
36316110	436	438	GC	Disease	MESH:D013274
36316110	710	714	PLK2	Gene	10769
36316110	773	775	GC	Disease	MESH:D013274
36316110	840	848	patients	Species	9606
36316110	858	862	PLK2	Gene	10769
36316110	863	871	rs963615	SNP	tmVar:rs963615;VariantGroup:2;CorrespondingGene:10769;RS#:963615;CorrespondingSpecies:9606
36316110	904	906	GC	Disease	MESH:D013274
36316110	923	931	patients	Species	9606
36316110	974	978	PLK2	Gene	10769
36316110	979	987	rs963615	SNP	tmVar:rs963615;VariantGroup:2;CorrespondingGene:10769;RS#:963615;CorrespondingSpecies:9606
36316110	1035	1052	vascular invasion	Disease	MESH:D009361
36316110	1068	1072	PLK3	Gene	1263
36316110	1073	1083	rs12404160	SNP	tmVar:rs12404160;VariantGroup:4;CorrespondingGene:1263;RS#:12404160;CorrespondingSpecies:9606
36316110	1133	1135	GC	Disease	MESH:D013274
36316110	1174	1177	ATM	Gene	472
36316110	1253	1255	GC	Disease	MESH:D013274
36316110	1271	1274	ATM	Gene	472
36316110	1275	1283	rs228589	SNP	tmVar:rs228589;VariantGroup:0;CorrespondingGene:472;RS#:228589;CorrespondingSpecies:9606
36316110	1285	1293	rs189037	SNP	tmVar:rs189037;VariantGroup:5;CorrespondingGene:472;RS#:189037;CorrespondingSpecies:9606
36316110	1299	1305	rs4585	SNP	tmVar:rs4585;VariantGroup:3;CorrespondingGene:472;RS#:4585;CorrespondingSpecies:9606
36316110	1376	1395	perineural invasion	Disease	MESH:D052958
36316110	1441	1447	cancer	Disease	MESH:D009369
36316110	1502	1506	PLK2	Gene	10769
36316110	1507	1514	rs15009	SNP	tmVar:rs15009;VariantGroup:1;CorrespondingGene:10769;RS#:15009;CorrespondingSpecies:9606
36316110	1550	1557	miR-23b	Gene	407011
36316110	1617	1625	patients	Species	9606
36316110	1631	1633	GC	Disease	MESH:D013274
36316110	1648	1652	PLK2	Gene	10769
36316110	1654	1658	PLK3	Gene	1263
36316110	1664	1667	ATM	Gene	472
36316110	1724	1726	GC	Disease	MESH:D013274
36316110	1766	1770	PLK2	Gene	10769
36316110	1771	1778	rs15009	SNP	tmVar:rs15009;VariantGroup:1;CorrespondingGene:10769;RS#:15009;CorrespondingSpecies:9606
36316110	1810	1812	5p	Chromosome	5
36316110	1894	1902	patients	Species	9606
36316110	1908	1910	GC	Disease	MESH:D013274
36316110	Association	MESH:D013274	RS#:15009;CorrespondingGene:10769
36316110	Association	MESH:D009369	RS#:15009;CorrespondingGene:10769
36316110	Association	MESH:D013274	RS#:189037;CorrespondingGene:472
36316110	Negative_Correlation	MESH:D013274	RS#:963615;CorrespondingGene:10769
36316110	Negative_Correlation	MESH:D052958	RS#:228589;CorrespondingGene:472
36316110	Positive_Correlation	MESH:D013274	RS#:12404160;CorrespondingGene:1263
36316110	Association	MESH:D009369	RS#:963615;CorrespondingGene:10769
36316110	Association	MESH:D013274	472
36316110	Association	MESH:D009361	10769
36316110	Negative_Correlation	MESH:D052958	RS#:4585;CorrespondingGene:472
36316110	Association	MESH:D013274	10769
36316110	Association	MESH:D013274	407011
36316110	Negative_Correlation	MESH:D009361	RS#:963615;CorrespondingGene:10769
36316110	Negative_Correlation	MESH:D052958	RS#:189037;CorrespondingGene:472
36316110	Association	MESH:D013274	RS#:228589;CorrespondingGene:472
36316110	Negative_Correlation	MESH:D052958	RS#:963615;CorrespondingGene:10769
36316110	Association	MESH:D013274	RS#:4585;CorrespondingGene:472
36316110	Association	MESH:D052958	472
36316110	Association	MESH:D013274	1263
36316110	Association	MESH:D009369	10769
36316110	Association	MESH:D013274	10769
36316110	Association	MESH:D009369	10769
36316110	Association	MESH:D013274	472
36316110	Association	MESH:D052958	472
36316110	Association	MESH:D013274	1263
36316110	Association	MESH:D009361	10769
36316110	Association	MESH:D052958	10769

